GnuBIO Inc. — Form D/A
GnuBIO Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2011-09-06. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-09-06
- Form: D/A
- Accession: 0001506709-11-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $8.0M
- Amount sold: $8.0M
- Minimum investment: $15K
- Investors: 12
- Date of first sale: 2010-11-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-151301
Issuer
- Name: GnuBIO Inc.
- CIK: 0001506709
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 1 KENDALL SQUARE, BLDG. 1400, CAMBRIDGE, MA, 02139
- Phone: 617-446-6744
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| John Boyce | Director | New York, NY |
| John Boyce | Executive Officer | New York, NY |
| David Weitz | Director | Del Mar, CA |
| David Weitz | Executive Officer | Del Mar, CA |
| David Bianchi | Director | Cambridge, MA |
| Marie-Claude Bernal | Director | Wellesley, MA |
| Boyce John | Director | Bridgewater, MA |
| Boyce John | Executive Officer | Bridgewater, MA |
| Boyce John | Promoter | Bridgewater, MA |
| Marie Claude Bernal | Director | Wellesley, MA |
| David Claude Weitz | Director | Cambridge, MA |
Other filings by this issuer (2)
More